Search
for
Sort by
Research 481–510 of 1000+
- Immunogenetic and metabolic risk factors in male androgenetic alopecia: the role of HLA-DRB1 alleles and vitamin D3 deficiency
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- A comparative study of microneedling with platelet-rich plasma plus topical minoxidil (5%) and topical minoxidil (5%) alone in androgenetic alopecia
- Is androgenetic alopecia a risk for atherosclerosis?
- Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: A randomized, double-blind placebo control trial
- Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation
- Body to scalp: Evolving trends in body hair transplantation
- The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia
- Androgenetic alopecia is associated with increased arterial stiffness in asymptomatic young adults
- Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist?
- Progressive expression of PPARGC1α is associated with hair miniaturization in androgenetic alopecia
- Preliminary Investigation on Micro-Needling with Low-Level LED Therapy and Growth Factors in Hair Loss Related to COVID-19
- Association of androgenetic alopecia and severity of coronavirus disease 2019
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Comparing the therapeutic efficacy of topical minoxidil and finasteride with topical minoxidil and oral finasteride in androgenetic alopecia: a randomized trial
- Genetic prediction of male pattern baldness based on large independent datasets
- Androgenetic alopecia and COVID‐19: Is there a clinical connection?
- Systematic investigation of a potential epidemiological and genetic association between male androgenetic alopecia and COVID‐19
- Sonographic comparison of subcutaneous fat layer thickness in the scalp area in patients with androgenetic alopecia compared to healthy individuals: Cross‐sectional
- An anti‐hair loss treatment in the management of mild androgenetic alopecia: results from a large, international observational study
- Adipose derived stem cell based therapies or male/female pattern hair loss
- Adipose derived stem cell based therapies or male/female pattern hair loss
- Correlation of trichoscopic findings with clinico-epidemiological factors in male pattern&nbsp;<span style="font-size: 1rem;">hairloss: A cross-sectional study from a tertiary care center in Chengalpattu</span>
- Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta.
- The Use of Botulinum Toxin in the Treatment of Androgenetic Alopecia: A Systematic Review
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- Prevalence of Metabolic Syndrome and Cardiovascular Risk Factors in Early Onset Male Androgenetic Alopecia - A Cross Sectional Study in a Tertiary Care Hospital
- Does Hair Loss Impact Mood, Self-esteem, Body Image, and Quality of Life in Patients of Androgenetic Alopecia?
- Association Between Smoking and Androgenetic Alopecia: A Cross-Sectional Analysis of Severity and Dose-Response Relationship in Adult Males
- [Translated article] High-dose Oral Minoxidil for the Treatment of Androgenetic Alopecia